The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew)

Journal of Neural Transmission

Volumn 106, Issue 11-12, 1999, Pages 1045-1061

  Darmani, N A ^a   Zhao, W ^a   Ahmad, B ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

7 (OH) DPAT; 907; Apomorphine; Cryptotis parva; Dopamine D2 receptor; Dopamine D3 receptor; Least shrew; PD 128; Quinpirole; Sulpride; U99194A

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; ANTIEMETIC AGENT; APOMORPHINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; QUINPIROLE; SULPRIDE; UNCLASSIFIED DRUG; (5,6 DIMETHOXYINDAN 2 YL)DIPROPYLAMINE; (5,6-DIMETHOXYINDAN-2-YL)DIPROPYLAMINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H (1)BENZOPYRANO(4,3 B) 1,4 OXAZIN 9 OL; 3,4,4A,10B-TETRAHYDRO-4-PROPYL-2H,5H-(1)BENZOPYRANO(4,3-B)-1,4-OXAZIN-9-OL; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; BENZOPYRAN DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; INDAN DERIVATIVE; OXAZINE DERIVATIVE; SULPIRIDE; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INSECTIVORE; MALE; NONHUMAN; PRIORITY JOURNAL; VOMITING; ANALYSIS OF VARIANCE; ANIMAL; BRAIN LEVEL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; SHREW; SPECIES DIFFERENCE;

ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; BENZOPYRANS; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INDANS; MALE; OXAZINES; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SHREWS; SPECIES SPECIFICITY; SULPIRIDE; TETRAHYDRONAPHTHALENES; VOMITING;

EID: 0033233152     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050222     Document Type: Article

References (35)

1. Andrews PLR, David CJ, Grahame-Smith DG, Maskell LB (1986) Apomorphine-induced vomiting in the ferret; abnormalities of response to dose and route of administration. Br J Pharmacol 89: 860P
2. Andrews PLR, Davis CJ, Maskett L (1990) The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 68: 325-345
3. 3 receptor antagonist PNU-99194A fails to block (+)-7-OH DPAT substitution for d-amphetamine or cocaine. Eur J Pharmacol 358: 101-109
4. 3 receptor preferring agonist to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. J Pharmacol Exp Ther 283: 794-799
5. Brunton LL (1996) Agents affecting gastrointestinal water, flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In: Hardman JG, Limbird LE (eds) Goodman and Gilman's: The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 917-936
6. Churchfield S (1990) The natural history of shrews. Cornell University Press, Comstock Publishing Associates, Ithaca NY
7. 2 dopamine receptor classification and its functional implications. Synapse 1: 347-388
8. 3 dopamine receptor antagonists using an ethologically based approach. Psychopharmacology (Berl) 136: 284-290
9. 3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis. J Neural Transm 105: 1143-1154
10. Darmani NA, Zhao W (1998) Production of serotonin syndrome by 8-OH DPAT in Cryptotis parva. Physiol Behav 65: 327-331
11. 1c-mediated phenomenon. Pharmacol Biochem Behav 48: 383-396
12. 2 receptor. Biochem Soc Transact 24: 193-198
13. 3 receptor antagonist. CNS Drug Rev 4: 42-53
14. Harding RK, Hugenholtz H, Kucharczyk J, Lemoine J (1987) Central mechanisms for apomorphine-induced emesis in the dog. Eur J Pharmacol 144: 61-65
15. Hyde TM, Knable MB, Murray AM (1996) Distribution of dopamine D1-D4 subtypes in human dorsal vagal complex. Synapse 24: 224-232
16. Ito C, Isobe Y, Kijima J, Kiuchi Y, Ohtsuki H, Kawamura R, Tsuchida K, Higuchi S (1995) The antiemetic activity of GK-128 in Suncus murinus. Eur J Pharmacol 285: 37-43
17. King GL (1990) Animal models in the study of vomiting. Can J Physiol Pharmacol 68: 260-268
18. 3 receptor mutant mice. J Neurosci 18: 2231-2238
19. Leslie RA, Shaw Y, Thejomayen M, Murphy M (1990) The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting. Can J Pharmacol 68: 279-288
20. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49: 231-252
21. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78: 189-225
22. Naylor RJ, Rudd JA (1996) Mechanisms of chemotherapy/radiotherapy induced emesis in animal models. Oncology 53 [Suppl 1]: 8-17
23. 1A-receptor agonists in Suncus murinus. Jpn J Pharmacol 285: 37-43
24. 3 agonist PD 128, 907. J Pharmacol Exp Ther 275: 1355-1366
25. 3 receptors mediate inhibition of dopamine neuronal activity? Biochem Soc Transact 24: 198-201
26. Seeman P, Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15: 264-270
27. Sokoloff P, Martres M-P, Giros B (1992) The third dopamine receptor (D3) as a novel target for antipsychotics. Biochem Pharmacol 43: 659-666
28. Storey VJ, Middlemiss DN, Reavill C (1995) Effect of haloperidol and (-) sulpride on dopamine agonist-induced hypoactivity. Neuropharmacology 34: 449-455
29. Tice MAB, Hashemi T, Taylor CA, Duffy RA, McQuade RD (1994) Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Pharmacol Biochem Behav 49: 567-571
30. 3 receptor antagonists in Suncus murinus. Jpn J Pharmacol 55: 107-113
31. Torii Y, Saito H, Matsuki N (1991b) 5-Hydroxytryptamine is emetogenic in the house musk shrew, Suncus murinus. Naunyn Schmiedebergs Arch Pharmacol 344: 564-567
32. Ueno S, Matsuki N, Saito H (1987) Suncus murinus: a new experimental model in emesis research. Life Sci 41: 513-518
33. 3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behavior. J Neural Transm 98: 39-55
34. 3 receptor agonist, 7-OH DPAT, causes vomiting in the dog. Life Sci 57: 347-350
35. 3 receptor in the area postrema in R( + )-7-OH DPAT-induced emesis in the ferret. Eur J Pharmacol 301: 143-149